{
  "denotations": [
    {
      "id": "T1",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 14,
        "end": 20
      }
    },
    {
      "id": "T2",
      "obj": "Chemical",
      "span": {
        "begin": 60,
        "end": 70
      }
    },
    {
      "id": "T3",
      "obj": "Disease",
      "span": {
        "begin": 125,
        "end": 128
      }
    },
    {
      "id": "T4",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 140,
        "end": 146
      }
    },
    {
      "id": "T5",
      "obj": "Disease",
      "span": {
        "begin": 165,
        "end": 168
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "21118736_18",
  "text": "In homozygous CYP3A5 * 3 carriers ( n = 252 ) , mean ( SD ) tacrolimus dose requirements remained significantly lower during DGF , while in CYP3A5 * 1 carriers with DGF ( n = 52 ) , lower mean dose requirements were observed only after postoperative day 4 ."
}
